Objective-The adaptive response to vascular injury is the formation of functional collateral vessels to maintain organ integrity. Many of the clinical complications associated with sickle cell disease can be attributed to repeated bouts of vascular insufficiency, yet the detailed mechanisms of collateral vessel formation after injury are largely unknown in sickle cell disease. Here, we characterize postischemic neovascularization in sickle cell disease and the role of neutrophils in the production of reactive oxygen species. Approach and Results-We induced hindlimb ischemia by ligation of the femoral artery in Townes SS (sickle cell) mice compared with AA (wild type) mice. Perfusion recovery, ascertained using LASER (light amplification by stimulated emission of radiation) Doppler perfusion imaging, showed significant diminution in collateral vessel formation in SS mice after hindlimb ischemia (76±13% AA versus 34±10% in SS by day 28; P<0.001; n=10 per group). The incidence of amputation (25% versus 5%) and foot necrosis (80% versus 15%) after hindlimb ischemia was significantly increased in the SS mice. Motor function recovery evaluation by the running wheel assay was also impaired in SS mice (36% versus 97% at 28 days post-hindlimb ischemia; P<0.001). This phenotype was associated with persistent and excessive production of reactive oxygen species by neutrophils. Importantly, neutrophil depletion or treatment with the antioxidant N-acetylcysteine reduced oxidative stress and improved functional collateral formation in the SS mice. Conclusions-Our data suggest dysfunctional collateral vessel formation in SS mice after vascular injury and provide a mechanistic basis for the multiple vascular complications of sickle cell disease. Visual Overview-An online visual overview is available for this article.
S
ickle cell disease (SCD) is the most common hemoglobinopathy worldwide. 1 A hallmark of the disease is repeated bouts of ischemia secondary to polymerizing sickle red blood cells. 2 This leads to vaso-occlusion and microvessel injury, 3, 4 as well as large vessel injury. [5] [6] [7] Consequently, the vast array of vascular complications in SCD, including strokes, retinopathy, sudden cardiac death, recalcitrant leg ulcers, kidney failure and other organ dysfunction, is likely multifactorial and complex. 2, 8, 9 A normal physiological response to vascular injury is the development of collateral vessels to preserve end-organ function. That these patients experience multiple vascular complications may suggest impairment in collateral vessel formation after ischemic injury. It is currently unknown whether collateral vessel formation is impaired in SCD.
The formation of collateral vessels is an incompletely understood, multifactorial process that involves the interplay of diverse cell types (immune cells and endothelial cells) and coordinated regulation of cytokines, chemokines, and other cellular and angiogenic factors. 10, 11 Reactive oxygen species (ROS), particularly H 2 O 2 and superoxide radicals (O 2 .− ), have emerged as critical mediators of collateral vessel formation. Specifically, we and others have shown that regulation of ROS is necessary to regulate the appropriate microenvironmental cues for effective collateral vessel formation. Either low or excessive production impairs collateralization. [12] [13] [14] Neutrophils-first responder cells after vascular injury -are a major source of ROS . 15 Furthermore, neutrophils may synthesize other chemokines and cytokines, such as metalloproteinases, that participate in collateral vessel formation. 16 In addition, they may interact with endothelium to cause direct injury. However, because these cells have short half-lives, they are thought to play negligent role in collateral vessel formation. However, as we show in this study, prolonged and persistent neutrophil infiltration is a striking characteristic of the ischemic response in SCD. Given that neutrophils propagate inflammation and oxidative stress in SCD, 17 we sought to examine their role in collateral vessel formation. We now show significant impairment in collateralization after hindlimb ischemia (HLI) in a mouse humanized with the sickle hemoglobin gene. This was associated with excessive H 2 O 2 and O 2 .− and a prominent role of neutrophils as a chief source of persistent ROS. Depletion of neutrophils and pharmacological reduction of oxidative stress improved collateral vessel formation in this mouse model of SCD. Our data, for the first time to our knowledge, reveal impaired postischemic neovascularization as a critical pathophysiologic underpinning of the multiple vascular complications in SCD and implicate neutrophils as a potential target to improve this process.
Materials and Methods

Animals
The humanized Townes SS (sickle cell) mice 18 were an original generous gift of Dr Townes (University of Alabama, Birmingham). The Townes mice, hα/hα::β A /β S , hα/hα::-383 γ-β A /-1400 γ-β S (Jax No. 013071) are on a mixed C57BL/6:129 background, and colonies were established, maintained, and bred in-house at the Emory University Department of Animal Resources. Female AA (wild type) mice (genotype AA) and littermate SS mice (genotype SS) between 8 and 12 weeks old were used for the described experiments. The animals were housed and cared for in agreement with the guidelines approved by the Emory University Institutional Animal Care and Use Committee.
Hindlimb Ischemia
Mice were anesthetized with 2% isoflurane in a chamber and then anesthetized with 2% isoflurane through a nose cone. A unilateral incision was made over the left medial thigh of the mouse. The superficial femoral artery and vein were ligated with 6-0 silk caudally to the branching deep femoral artery. A second ligation was performed just proximal to the branching of the tibial arteries, and the length of the artery and vein was excised between the 2 ligation points. The skin was closed with monofilament suture. The animals received buprenorphine (0.1 mg/kg, subcutaneously) for analgesia and were allowed to recover on a heated pad.
LASER Doppler Perfusion Imaging
LASER (light amplification by stimulated emission of radiation) Doppler perfusion imaging (LDPI) was performed as described previously. 14, 19 Briefly, mice were anesthetized by inhalation of 2% isoflurane and scanned with the LDPI system (PIM II Laser Doppler Perfusion Imager; Perimed). By defining equivalent regions of interest on the perfusion heat map generated by the instrument and calculating the mean perfusion (in arbitrary perfusion units) in both the proximal and distal leg regions, perfusion in the ischemic leg was normalized to flow in the nonischemic leg.
Histological Assessment of Vessel Density
Histological analysis was performed on both the ischemic and nonischemic limbs at indicated days post-HLI surgery. Mice were euthanized, and the tissue was perfused with saline followed by 10% buffered formalin for fixation. The bone was then demineralized in a formic acid-based solution (Cal-Ex II; Fisher Scientific) for 48 hours before processing and paraffin embedding. Sections that were 5 μm thick were prepared for staining. Enzyme treatment was performed in 2 μg/mL proteinase K ( 
In Vivo Staining by Tail Vein Injection of Lectin for Confocal Imaging
One hundred microliters of 1 mg/mL fluorescein isothiocyanateconjugated GSL I (griffonia simplicifolia lectin I; Cat No. FL-1201; VectorLab) was injected intravenously and allowed to circulate for 10 minutes before mice were euthanized and hindlimb muscles were harvested. Tissues were fixed in 10% buffered formalin at 4°, incubated in 30% sucrose for 24 hours, embedded in optimal cutting temperature compound, snap-frozen, and cryosectioned (50-μm-thick sections). Sections were mounted with Vectashield with DAPI (4',6-diamidino-2-phenylindole, dihydrochloride; Cat No. H-1200; VectorLab). Perfused vessels were identified as fluorescein isothiocyanate-I-labeled lumenal structures on confocal laser scanning microscope and reported as vessels per mm 2 . ImageJ software (National Institutes of Health) was used to count the number of vessels for analysis.
Vascular Leakage Assay
The integrity of collateral vessels formed after HLI was assessed by a modified Miles assay. 20 Twenty-eight days after HLI, mice underwent intravenous injection of 100 μl of 1% cell-impermeable Evans Blue dye (Sigma-Aldrich, St. Louis, MO) via the tail vein. After 40 minutes, the animals were euthanized, and hind limbs were isolated and incubated in formamide (Cat No. 11814320001; Sigma) for 3 days to extract the dye, and the optical density was determined at 620 nm.
Running Wheel Study
The measurement of voluntary running endurance was performed as a physiological test of ischemic limb functional recovery. On postoperative day 21 or 28, each mouse was individually housed in a cage with a running wheel attached to a sensor that counted the number of revolutions made by the wheel during a 7-day period. The distance in meters was recorded both daily and cumulatively for 7 days.
H 2 O 2 Measurement
Extracellular H 2 O 2 produced from nonischemic and ischemic tibialis anterior muscles was measured by Amplex red assay ( Cat No. A22188; Invitrogen, Carlsbad, CA), according to manufacturer's instructions as described previously.
14 H 2 O 2 production was normalized to tissue wet weight. For intracellular ROS , single-cell suspensions were obtained by digesting hind limbs in collagenase-dispase solution. Cells were then incubated with 5 μM of 5-(and-6)-chloromethyl-2′,7′-dichlorodihydrofluorescein diacetate, acetyl ester (CM-H2DCFDA, Cat No. C6827; Invitrogen) at 37°C for 15 minutes, before analysis by flow cytometry. Neutrophils were identified with surface marker staining with anti-Gr-1 antibody (Cat No. 108411; Biolegend).
Tissue Superoxide Measurement
Superoxide production by ischemic muscles was measured using Hydro-Cy5 probe (ROSstar 650, Cat No. 926-30000; LI-COR Biosciences). After digestion of ischemic tissue as described previously, equal number of cell lysates were seeded in triplicates in a 96-well plate, and fresh Hydro-Cy5 probes were prepared at 25 µmol/L and incubated with samples for 20 minutes at room temperature in the dark, before fluorescence was read at emission/excitation 635/660 nm. Control wells were cell lysates without probe.
Neutrophil Depletion
After HLI, neutrophils were depleted by intraperitoneal injection of 100 µg of monoclonal anti-mouse Ly6G antibody (clone 1A8, Cat No. 
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Antioxidant Therapy
SS mice were treated with 0.163 g/L N-acetyl cysteine (Cat No. A7250; Sigma-Aldrich) in their drinking water. Fresh drinking water was made every 2 days.
5/6 Nephrectomy
Animals underwent 5/6 nephrectomy or sham surgery under 2% isoflurane anesthesia and buprenorphine (0.1 mg/kg, subcutaneously) for analgesia. Briefly, the left kidney was exposed, and the upper and lower poles were tied with a polyglycolic acid suture line. The peritoneum and skin were then sutured, and the animals were returned to their individual cages. A week later, complete right nephrectomy was performed. Mice recovered completely, and hematocrit was monitored to ensure anemia before HLI was performed.
Iron-Deficiency Anemia
To induce anemia, a cohort of AA mice were fed iron-deficient diet (≈3 ppm Fe, TD.80396, Teklad Diets) compared with standard chow (48 ppm Fe) for at least 6 weeks before HLI and throughout their time course after surgery. Mice on the iron-deficient diet underwent additional weekly submandibular bleed (250-300 µL) to ensure severe anemia. Complete blood counts were measured by a Hemavet 1500 blood analyzer (CDC Technologies, Oxford, CT).
Statistical Analysis
All reported results are expressed as mean±SEM. Graphpad Prism (Graphpad Software, La Jolla, CA) was used for statistical analysis. Blood flow recovery in the ischemic hindlimb was compared between the 2 groups by 2-way repeated measures ANOVA, followed by Bonferroni post hoc analysis. Comparison between groups was analyzed by unpaired 2-tailed Student t test or ANOVA for experiments with >2 subgroups followed by Bonferroni post hoc analysis. For categorical data, Pearson χ 2 analysis was performed. A P value of <0.05 was considered statistically significant.
Results
Impaired Collateral Vessel Formation After HLI
To investigate collateral vessel formation in SS mice, we used the HLI model. All mice survived after induction of unilateral HLI and appeared healthy during the follow-up period. Perfusion was quantified using LDPI. There were no differences in limb perfusion between AA and SS mice at baseline ( Figure I in the online-only Data Supplement). After HLI, the perfusion measurements in SS and AA mice were similar at the earliest time points (days 0 through 7), suggesting equivalent extent of vascular injury ( Figure 1B) . However, whereas AA mice showed continued perfusion recovery over time, SS mice demonstrated significant impairment in perfusion recovery ( Figure 1A and 1B). For instance, at day 28 post-HLI, perfusion recovery was 76±13% in AA, compared with 34±10% in SS mice, P<0.001. In addition, the incidence of digit necrosis after HLI exceeded 80% in SS mice, compared with 15% in the AA mice, P<0.01 ( Figure 1C) . Furthermore, the incidence of limb amputation was 25% in the SS mice, compared with 5% in AA mice, P<0.01 ( Figure 1D ). Spontaneous functional muscle recovery was analyzed by distance covered on a computerized running wheel attached to mouse cages. In this assay ( Figure 1E ), spontaneous muscle activity recovery was impaired in SS mice, whereas AA mice recovered nearly full muscle function by 28 days (38.4% versus 96.8%). Altogether, these data demonstrate impaired functional collateral vessel formation in SS mice after ischemic injury. To further characterize the response to ischemic injury, we performed histological and immunohistochemical analyses. Histology at 28 days revealed markedly increased areas of tissue necrosis, loss of muscle mass, and persistent inflammation in the SS ischemic limb. In contrast, AA ischemic limbs demonstrated muscle mass integrity, resolved necrosis, and inflammation (Figure 2A) . At 28 days, there was no difference between the genotypes in terms of quantity of smooth muscle-positive vessels as evaluated by αSMA (α smooth muscle actin) staining ( Figure 2B ). However, immunofluorescence analysis from in vivo fluorescein isothiocyanate lectinperfused mice revealed that SS mice had a morphologically disorganized, noncontiguous, and fewer lectin-positive vasculature (a representative Z-stack confocal imaging is shown in Figure 2C ). Furthermore, in vivo injection of membraneimpermeable Evans Blue dye-a common approach to evaluate vessel integrity-disproportionally accumulated in the ischemic hindlimb of the SS mice ( Figure 2D ), suggesting dysfunctional, leaky vessels. We also performed additional experiments by Hematoxylin and Eosin analysis of nonperfusion fixed ischemic tissues to access small vessel patency. Representative data are shown in Figure 2E . This analysis showed that SS small vasculatures (capillaries, venules, and arterioles) were not occluded by sickling red cells. Thus, the poor collateral vessel formation in the SS cannot be fully explained by acute vessel occlusion by local sickle crises.
Townes SS mice are severely anemic (Table I in the onlineonly Data Supplement). 21 In certain clinical and experimental contexts, anemia may impact collateral vessel formation. [22] [23] [24] To determine the influence, if any, of anemia on the impaired collateral vessel formation in the SS mice, we induced severe anemia in AA mice by performing 5/6 nephrectomy. The hemoglobin of these mice was 9.2±0.3 g/dL at the time of HLI (Table I in the online-only Data Supplement). AA mice that underwent 5/6 nephrectomy showed no impairment in collateral vessel formation as measured by perfusion recovery with LDPI ( Figure IIA in the online-only Data Supplement). A second approach, using iron-deficient diet with weekly phlebotomy, was used to induce anemia. Long-term irondeficient diet with weekly phlebotomy significantly reduced hemoglobin (11.3±0.2 g/dL) compared with mice fed standard diet (14.5±0.4 g/dL; P<0.01). These anemic mice also showed equivalent collateral vessel formation compared with nonphlebotomized mice fed the standard chow ( Figure IIB in the online-only Data Supplement). These sets of experiments demonstrate that anemia independently does not play a significant role in the poor perfusion recovery and functional outcomes in the SS mice after HLI.
Increased ROS in the Ischemic Limb of SS Mice
To determine the mechanisms contributing to the impaired collateral vessel formation, we focused on the role of ROS, specifically H 2 O 2 and superoxide (O 2 .− ). We and others have shown the critical role of these molecules in collateral vessel formation. 12, 14 Specifically, an appropriate amount of H 2 O 2 is necessary to orchestrate multiple of the mechanisms required for collateral vessel formation, but excessive H 2 O 2 may be detrimental. We first measured H 2 O 2 levels in hindlimb of SS Figure 2 . Histological analysis of ischemic limb in SS (sickle cell) and AA (wild type) mice 28 d after hindlimb ischemia (HLI). A, Representative trichrome staining showed significant loss of muscle mass, tissue necrosis (blue staining), and excessive inflammation in SS mice compared with AA mice (scale bar=40 µm). B, Representative αSMA (α smooth muscle actin) staining showed no difference between SS and AA (scale bar=200 µm). C, Representative Z-stack confocal microscopy of fluorescein isothiocyanate lectin-perfused vessels showing significantly decreased functional vessel formation (scale bar=100 µm). Number of lectin-perfused vessels per mm 2 is indicated. D, Mice were injected with Evans Blue dye, and spectrophotometric absorbance of harvested ischemic (IL) and nonischemic (NIL) limbs was read at 620 nm to evaluate vascular leakage. E, Representative Hematoxylin and Eosin of nonperfused blood vessels showing patency in the SS. n=4 to 6 mice per genotype per indicated study. Data are plotted as mean±SEM. *P<0.05, **P<0.01, ***P<0.001. mice and repeatedly found significantly increased amounts of H 2 O 2 at 3, 5, and 7 days after HLI ( Figure 3A ). Of note, there was no difference in H 2 O 2 production in the nonischemic limbs of the AA and SS mice (data not shown). These data suggest that overproduction of H 2 O 2 may contribute to the impaired postischemic neovascularization in the sickle mice. Similarly, we found significantly elevated levels of O 2 .− in the ischemic limbs of the SS mice, compared with the AA mice ( Figure 3B ).
SS Neutrophils Produce Elevated ROS
To identify the cellular source of ROS, we assessed the HLI tissues by histology and immunohistochemistry. The excessive inflammation and necrosis in the SS hind limbs prompted evaluation of neutrophils. Interestingly, we noted persistent neutrophils in the ischemic limbs of the SS mice beyond day 3, and ≤28 days after HLI ( Figure 4A ). Because neutrophils are an important source of ROS and have been previously described to be highly inflammatory in SCD, 17, 25 we used flow cytometry to measure intracellular H 2 O 2 in the neutrophils in the context of HLI using the DCFDA (2',7'-dichlorodihydrofluorescein diacetate) probe. We found a 2.5-fold increased H 2 O 2 production in SS neutrophils compared with AA neutrophils in the ischemic tissue ( Figure 4C) . Thus both the total number of infiltrating neutrophils and the production of H 2 O 2 by these neutrophils were increased in the SS mice.
Neutrophil Depletion Improves Collateral Vessel Formation
We reasoned that if neutrophils contributed to excessive ROS, then elimination of neutrophils would reduce ROS levels and potentially improve collateral vessel formation in SS mice. To test this, we used the monoclonal anti-Ly6G antibody to deplete neutrophils in the SS mice. Control SS mice were treated with IgG2a. Injection every 2 days successfully depleted neutrophils in the SS mice ( Figure 5A ). Neutrophil depletion significantly improved collateral vessel formation in the SS mice, beginning at day 14 through 28, as shown in Figure 5B . Functional muscle recovery ( Figure 5C ) significantly improved in SS mice treated with anti-LyG antibody (620 versus 1540 m per day; P<0.01) with an insignificant trend toward improvement in toe necrosis and limb amputation after neutrophil depletion (data not shown). Importantly, neutrophil depletion was associated with significant reduction in both H 2 O 2 and O 2 .− in the ischemic limb of the SS mice ( Figure 5C and 5D ). Not surprisingly, depletion of neutrophils in AA mice did not significantly impact collateral vessel formation ( Figure III in the online-only Data Supplement).
Reduced Oxidative Stress Improves Collateral Vessel Formation in SS Mice
Excessive oxidant stress has been shown to inhibit collateral vessel formation in diabetes mellitus. 26 To directly demonstrate that excessive ROS impairs collateral vessel formation in SS mice, we treated SS mice with the potent antioxidant N-acetylcysteine (NAC), starting 7 days before HLI. LDPI measurements and the running wheel experiments showed that treatment with NAC significantly improved perfusion recovery in the ischemic limb of SS mice after HLI. For example, at 3 weeks post-HLI, SS mice showed 43±3% recovery versus 29±2% untreated (P<0.05). This was associated with increased spontaneous motor functional recovery on the running wheel, 28 days after HLI ( Figure 6B ), improvement in extent of toe necrosis (76% versus 45%; P<0.01), and improvement in the incidence of limb amputations after ischemia (25% versus 10%; P<0.01). Importantly, NAC treatment also significantly reduced the excessive H 2 O 2 and O 2 .− production in the SS mice 3 days after HLI ( Figure 6C and 6D) . Thus, as in diabetes mellitus models, antioxidant therapy dampens excessive ROS production and improves collateral vessel formation in SS mice. NAC treatment in AA mice did not significantly impair collateral vessel formation ( Figure IVA and IVB in the onlineonly Data Supplement).
Discussion
Collateral formation in response to tissue ischemia is an important adaptive mechanism necessary for maintenance of endorgan function. For SCD where repeated bouts of ischemic injury are common, this adaptive process is even more vital to protect from both small and large vessel complications. We Figure 3 . Excessive reactive oxygen species production in ischemic SS (sickle cell) limbs. A, The Amplex red assay was used to measure H 2 O 2 levels in ischemic hind limbs (IL) of SS and AA (wild type) mice. H 2 O 2 measurements were normalized to tissue wet weight. H 2 O 2 was increased in the IL in the SS mice at 3, 5, and 7 d with a peak at day 5. n=5 mice per time point. B, The hydro-Cy5 dye was used to measure superoxide levels in the IL of SS and AA mice (n=5 per group) 3 d after ischemia. Cell homogenate from ischemic AA and SS mice were incubated with hydro-Cy5 dye, and fluorescence of the microplate was read at em/ex 635/660 nm. Bars are means±SEM. *P<0.05.
hypothesized that patients with sickle cell experience numerous vascular complications, including strokes, increased morbidity from stroke, sudden cardiac death, and recalcitrant leg ulcers, among others, because of potentially impaired collateralization after vessel injury. Indeed the development of the dysfunctional microvessels in Moyamoya syndrome 27 -a common finding in SCD-provides additional evidence for likely impaired collateralization after vessel injury. However, to our knowledge, the process of collateral vessel formation after injury has not been previously described in an SCD mouse model. Using the HLI model, we found significant impairment in functional collateral vessel formation in SS mice, resulting in an increased incidence of amputation, toe necrosis, and impaired recovery of muscle function. Although HLI is a common model to investigate peripheral artery disease, an atypical clinical complication of SCD, this model is an ideal testbed to study collateral vessel formation because it allows for extensive functional, physiological, and anatomic characterization in vivo. Indeed, peripheral artery disease may be uncommon in SCD, in part, because it is a disease of the elderly, whereas life expectancy among patients with SCD is markedly lower than the general population. 28, 29 Nonetheless, large vessel vasculopathy is an underappreciated potential complication of SCD, 30 and our findings suggest that impaired functional collaterals may contribute to this pathophysiology.
Direct vaso-occlusion of small vessels leads to tissue ischemia. In our model, careful analysis of ischemic tissue did not reveal complete occlusion of vessels by sickling red blood cells. Thus, although we cannot rule this out, direct sickling apparently plays a minor role in our model. Rather, the excessive inflammatory response and ROS were the most striking features in the SS mice. The role of ROS as mediators that orchestrate various aspects of collateralization is well described by our previous studies and by others. Specifically, a fine balance of ROS is necessary to sustain collateral formation after ischemia: both excessive levels as in diabetes mellitus and low levels as in NADPH-deficiency states are detrimental to functional collateral formation. 12, 13, 26, 31 It has previously been shown that infiltrating inflammatory cells contribute ROS in the acute phase of HLI, followed by neovascular endothelial cells playing a more prominent role at later time points. 32 However, the contribution of neutrophils in neovascularization has received minimal attention, in part, because this important cellular source of ROS is often considered a transient first responder population. Only recently have neutrophils received greater attention as a potential modulator of diseases of chronic inflammation. 33 Here, we show that in the SS mice, neutrophils play a detrimental role by contributing excessive amounts of ROS. Depletion of neutrophils with a monoclonal antibody and reduction of oxidative stress by NAC treatment both significantly improved collateral vessel formation in SS mice. Additional work is required to delineate the mechanisms of the enhanced inflammatory and oxidative potential of neutrophils from SS mice, as well as the perplexing finding of persistent neutrophils within the ischemic tissue days after vascular injury. Understanding these mechanisms might provide novel strategies to promote the resolution of inflammation in SCD. Interestingly, the dose of NAC did not significantly impact perfusion recovery in AA mice, although previous studies have demonstrated that NAC treatment may impair collateral vessel formation in nondiseased mice. 13, 26 This discrepancy may be because of the dose used in our study, which may impact the optimal window of ROS levels necessary to promote collateralization. In addition, depletion of neutrophils did not significantly impact collateral vessel formation in the AA mice-a finding that is perhaps unsurprising-given that these cells are rapidly cleared in the ischemic limbs of the AA mice.
Our study does not address the potential contribution of ROS by other important cellular sources, such as macrophages, smooth muscle cells, and endothelial cells. Here, we focused on neutrophils given the striking histological finding of excessive neutrophil infiltration in ischemic sickle cell tissue and the well-documented observation of neutrophil activation in SCD. 34, 35 In our experiments, antioxidant therapy improved collateral formation with significantly greater inhibition of ROS compared with neutrophil depletion alone, suggesting that other cell types, such as macrophages, contribute to ROS and impaired collateral formation in SS mice. Further work is required to identify the role of these cells because they interact intimately with neutrophils in propagating inflammation in SCD and other inflammatory conditions. Indeed, neither neutrophil depletion nor NAC therapy improved collateral vessel formation to the level of AA mice. This clearly underscores the complex mechanisms involved in functional collateral formation after ischemia; other aspects of collateral formation may be differentially regulated in the SS compared with the AA mice. Additionally, work also required to delineate the mechanisms of the enhanced inflammatory and oxidative response of neutrophils from the SS mice, as well as the perplexing finding of persistent neutrophils within the ischemic tissues for several weeks after vascular injury. Understanding these mechanisms might provide novel strategies to promote the resolution of inflammation in SCD.
In summary, our study shows a previously unappreciated deficit in functional collateral vessel formation in SCD after vascular injury. Neutrophil-mediated excessive ROS production plays a critical role in this deficiency. In recent years, it has become apparent that small and large vessel complications of SCD, such as strokes, Moyamoya syndrome, cardiomyopathy, and sudden cardiac deaths, 8, 27, 36 are not merely secondary to red cell biology but also inflammatory pathophysiology. These vascular complications are likely to increase as the life expectancy of patients with sickle cell improves with emerging therapies. Targeting neutrophils and oxidative stress may improve the neurovascular and cardiovascular consequences of SCD.
